Available as a global test only. Markers tested by flow cytometry include CD19, CD20, CD27, CD38, CD45, CD56, CD117, CD138, cKappa, and cLambda.
disease state indication(s)
Multiple myeloma (MM)
The Myeloma MRD Profile by flow cytometry evaluates for the presence of minimal residual disease (MRD) in patients with previously diagnosed and treated multiple myeloma. The limit of detection is 0.01%.
specimen type and requirements
Bone marrow: 2-3 mL in sodium heparin (green-top) tube.
Note: Use refrigerated cold pack for transport. Make sure cold pack is not in direct contact with specimen.
DO NOT FREEZE. Transport to lab ASAP.
NY Clients – Please provide Date and Time of Collection.
Global (TC & PC): 24-48 hours
medicare moldx cpt code
Laboratory developed test (LDT)
Global (TC & PC)